JTJapan Times·1hHealth
score-0.30
Health Ministry Reviews Data Behind 2022 Approval of Tavneos, a Drug Listed with Liver Dysfunction Risk
Original
Health ministry questions reliability of vasculitis drug approval data
“Professional skepticism regarding regulatory integrity and drug safety creates a tone of prudent concern rather than alarm.”